These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9523745)

  • 1. Anti-D: mechanisms of action.
    Ware RE; Zimmerman SA
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):14-22. PubMed ID: 9523745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR; Lazarus AH
    Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced efficacy of anti-D immunoglobulin for treating ITP is not explained by higher immunoglobulin polymer content.
    Dolman C; Thorpe SJ; Thorpe R
    Biologicals; 2001 Jun; 29(2):75-9. PubMed ID: 11580212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin and anti-RhD therapy in the management of immune thrombocytopenia.
    Cooper N
    Hematol Oncol Clin North Am; 2009 Dec; 23(6):1317-27. PubMed ID: 19932436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC
    Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complexes as therapy for autoimmunity.
    Clynes R
    J Clin Invest; 2005 Jan; 115(1):25-7. PubMed ID: 15630438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Golla S; Horkan C; Dogaru G; Teske TE; Christopher K
    Acta Haematol; 2008; 120(2):100-3. PubMed ID: 18957844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-Rh(D): an efficacious therapeutic alternative in autoimmune hemocytopenias].
    Mascarin M; Trovò MG; Ventura A
    Pediatr Med Chir; 1993; 15(4):349-52. PubMed ID: 8265453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spleen and splenectomy in immune (idiopathic) thrombocytopenic purpura.
    Sandler SG
    Semin Hematol; 2000 Jan; 37(1 Suppl 1):10-2. PubMed ID: 10676918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
    Simpson KN; Coughlin CM; Eron J; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):58-64. PubMed ID: 9523750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura.
    Scaradavou A; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):52-7. PubMed ID: 9523749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety profile of WinRho anti-D.
    Hong F; Ruiz R; Price H; Griffiths A; Malinoski F; Woloski M
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):9-13. PubMed ID: 9523744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ; Balthasar JP
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD; Francischetti MM
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM; El-Agnaf M
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of antibody-coated liposomes as a new treatment for immune thrombocytopenia.
    Deng R; Balthasar JP
    Int J Pharm; 2005 Nov; 304(1-2):51-62. PubMed ID: 16171959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.